The main market opportunities in the RSV prophylaxis field lie in the development of new monoclonal antibodies and vaccines, with substantial growth expected due to late-stage pipeline products. This ...
Only 26% of Wisconsinites got a flu shot this fall ahead of an influenza season dominated by a potentially severe strain of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback